Cabergoline Oral Tablet 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cabergoline: Oral tablet (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8863.JPG
Cabergoline 0.5mg Tab
Par Pharmaceutical Inc
Pill Identification: 673  |  P P
Drug Image file DrugItem_9140.JPG
Cabergoline 0.5mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: LOGO 0.5  |  5420
Drug Image file DrugItem_14515.JPG
Cabergoline 0.5mg Tab
Actavis Inc. formerly Cobalt Laboratories a division Watson Laboratories, Inc.
Pill Identification: LOGO LOGO  |  C 5

What is this Medicine?

Cabergoline (ca BER goe leen) is used to treat high levels of prolactin. This is a hormone made by the body that affects things like the menstrual cycle, breast milk production, fertility, and sexual function. This medicine also treats high levels of prolactin caused by certain tumors.

Similar Brand Name Drugs : Dostinex: Oral tablet (0.5mg)
CVS Pharmacy Patient Statistics for Cabergoline: Oral tablet(0.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Cabergoline 0.5mg Tablet

NDC: 498840673
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Pituitary Adenoma, Restless Legs Syndrome (RLS), Parkinson's Disease, Hyperprolactinemia

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Cabergoline 0.5mg Tablet
Drug Image file DrugItem_8863.JPG
Par Pharmaceutical Inc
Pill Identification: 673  |  P P
Shape: oval
Color: white

Reported Side Effects for Cabergoline 0.5mg Tablet

Stuffy Nose Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Acne Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Menstrual Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Gas Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Breast Pain Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Throat Irritation Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Hot Flashes Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Tooth Pain Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
5.0-7.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
6.0-9.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
7.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
15.0-17.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
26.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
27.0-29.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Cabergoline 0.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Tobacco and Cabergoline 0.5mg Tablet(Cabergoline)
Tobacco and Cabergoline(Cabergoline)
In theory, side effects from Cabergoline may potentially get worse if you take Nicotine (examples: Nicotine patches or gum) or if you smoke tobacco. Contact your health care provider if you notice any changes in your blood pressure or other effects while taking Cabergoline with Nicotine-containing products.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cabergoline

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.